In vitro activities of OPT-80 and comparator drugs against intestinal bacteria

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4898-4902

  Finegold, Sydney M ^a,b   Molitoris, Denise ^a   Vaisanen, Marja Liisa ^a   Song, Yuli ^a   Liu, Chengxu ^a   Bolaños, Mauricio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; LINEZOLID; METRONIDAZOLE; OPT 80; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CLOSTRIDIUM; COMPARATIVE STUDY; ENTEROCOCCUS; GRAM NEGATIVE AEROBIC RODS AND COCCI; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; FECES; GLYCOSIDES; INTESTINES;

EID: 9644257232     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4898-4902.2004     Document Type: Article

References (19)

1. Ackermann G., B. Loffler, D. Adler, and A. C. Rodloff. 2004. In vitro activity of OPT-80 against Clostridium difficile. Antimicrob. Agents Chemother. 48:2280-2282.
2. Bartlett, J. G. 1992. Antibiotic-associated diarrhea. Clin. Infect. Dis. 15:573-581.
3. Collins, M. D., P. A. Lawson, A. Willems, J. J. Cordoba, J. Fernandez-Garayzabal, P. Garcia, J. Cai, H. Hippe, and J. A. E. Farrow. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812-826.
4. Derlot, E., and P. Courvalin. 1991. Mechanisms and implications of glycopeptide resistance in enterococci. Am. J. Med. 91:82S-85S.
5. Fekety, R. 1997. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am. J. Oastroenterol. 92:739-750.
6. Finegold, S. M., G. E. Mathisen, and W. L. George. 1983. Changes in human intestinal flora related to the administration of antimicrobial agents, p. 355-446. In D. J. Hentges (ed.), Human intestinal microflora in health and disease. Academic Press, Inc., New York, N. Y.
7. Finegold, S. M., D. Molitoris, Y. Song, C. Liu, M.-L. Vaisanen, E. Bolte, M. McTeague, R. Sandler, H. Wexler, E. M. Marlowe, M. D. Collins, P. A. Lawson, P. Summanen, M. Baysaller, T. J. Tomzynski, E. Read, E. Johnson, R. Rolfe, P. Nasir, H. Shah, D. A. Haake, P. Manning, and A. Kaul. 2002. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35(Suppl. 1):S6-S16.
8. Hershberger, E., S. Donabedian, K. Konstantinou, and M. J. Zervos. 2004. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin. Infect. Dis. 38:92-98.
9. Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155.
10. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology-manual, 6th ed. Star Publishing Co., Belmont, Calif.
11. Kucers, A., and N. M. Bennett. 1987. The use of antibiotics, 4th ed. J.B. Lippincott Co., Philadelphia, Pa.
12. Medical Economics Staff (ed.). 2003. Physicians' desk reference, 57th ed. Thomson Healthcare, Montvale, NJ.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 4th ed. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard, 5th ed. NCCLS document M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Smith, T. L., M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, F. C. Tenover, M. J. Zeros, J. D. Band, E. White, and W. R. Jarvis. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 340:49-53.
16. Swanson, R. N., D. J. Hardy, N. L. Shipkowitz, C. W. Hanson, N. C. Ramer, P. B. Fernandes, and J. J. Clement. 1991. In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Antimicrob. Agents Chemother. 35:1108-1111.
17. Tacconelli, E., M. Tumbarello, K. Donati, M. Bettio, T. Spanu, F. Leone, L. A. Sechi, S. Zanetti, G. Fadda, and R. Cauda. 2001. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin. Infect. Dis. 33:1628-1635.
18. Theriault, R. J., J. P. Karkowski, M. Jackson, R. L. Girolami, B. N. Sunga, C. M. Vojtko, and L. J. Coen. 1987. Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation, and antibacterial activity. J. Antibiot. 40:567-574.
19. Volaard, E. J., and H. A. L. Clasener. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.